A b s t r a c t
Carcinosarcoma of the uterus has been poorly characterized on cervicovaginal (Pap) smears, and we examine whether they effectively screen for carcinosarcoma and whether an abnormal Pap smear result has any clinical importance. Twenty-five patients with histologically confirmed carcinosarcoma had a conventional Pap smear shortly before diagnosis. Eleven smears (44%) originally were read as abnormal (malignant or atypical), and 4 additional cases were read as abnormal on retrospective review (15/25 [60%]). All malignant elements were epithelial, and 2 cases (8%) had atypical spindle cells, but no diagnostic sarcoma. Cervical involvement was the only histologic parameter correlating with an abnormal Pap smear result (P = .04). Univariate analysis found stage III or IV disease was an adverse prognostic sign compared with stage I or II disease (mean survival, 8 vs 36 months, respectively; P = .001), and multivariate analysis indicated that an abnormal Pap smear result correlated with worse survival (P = .023). The conventional Pap smear is insensitive (60%) for detecting carcinosarcoma, but when the result is abnormal, the Pap is an important stage-independent adverse prognosticator.
Carcinosarcoma, earlier known as malignant mixed mesodermal/müllerian tumor, is an uncommon uterine tumor that occurs principally in older women. The tumor typically appears grossly as a large intrauterine mass that often fills and expands the endometrial cavity and histologically discloses a mixture of malignant epithelial and mesenchymal elements. These tumors usually are associated with a poor prognosis. Our study had 3 aims: (1) test whether the routine Papanicolaou (Pap) smear effectively screens for the detection of carcinosarcoma, (2) search for consistent findings to recognize carcinosarcoma on Pap smears, and (3) examine whether the finding of an abnormal smear has independent clinical significance.
Materials and Methods
With institutional review board approval, all cases of uterine carcinosarcoma diagnosed from January 1983 through December 2003 were retrieved from the Duke University Medical Center (Durham, NC) Department of Pathology files. Cases were included only if an antecedent Pap smear was obtained within 6 months of the histologic diagnosis and both the Pap and histologic slides were available for review.
The conventional Pap smears were reviewed in a blinded manner by two of us (M.J.S. and L.G.D.) and classified as diagnostic of malignancy, "suspicious for" malignancy, or negative for malignancy. The smears were further evaluated qualitatively by cellular components present (eg, mesenchymal or epithelial elements). The sarcomatous component was classified histologically on the surgical specimen (eg, sarcoma not otherwise specified, rhabdoid, chondroid, or lipomatous differentiation) and compared quantitatively with the histologic types of carcinoma present (eg, endometrioid, serous, squamous, clear cell, and mucinous). The Pap smear findings then were correlated with the presence and site of metastasis, uterine cervix involvement, presence and extent of myometrial invasion, and lymphatic or vascular invasion. Data about clinical stage, length of time to and site of recurrence, and outcome were analyzed.
Statistical Analysis
We used χ 2 tests to compare categorical variables. KaplanMeier plots and log-rank tests were used to relate single prognostic variables to survival time. The Cox proportional hazards model was used for multivariate analysis of survival. 1
Results
Twenty-five conventional Pap smears were identified and reviewed using the aforementioned criteria. All cases had histologic confirmation by endometrial biopsy (5 cases) or hysterectomy (20 cases). Eleven (44%) of the Pap smears originally were read as malignant or atypical, and 4 additional cases were classified as atypical on retrospective review, for a sensitivity of 60% (15/25) ❚Table 1❚. No cases originally read as negative were reclassified as diagnostic of malignancy.
The 4 cases found to be atypical on review had few or small clusters of atypical epithelial cells. The malignant or atypical elements were epithelial in all 15 cases ❚Image 1❚ and ❚Image 2❚. Of these, 7 (47%) originally were diagnosed as adenocarcinoma of likely endometrial origin, 2 (13%) as squamous cell carcinomas (no squamous carcinoma present histologically within the carcinosarcoma), and 1 (7%) as poorly differentiated carcinoma. The remaining 5 cases were not otherwise classified. Two Pap smears (8%; cases 2 and 6) disclosed atypical spindle cells (Image 1A), but no smear revealed diagnostic sarcomatous elements. Case 6 with atypical spindle cells had a large sarcomatous component in the surgical specimen (95% was sarcoma), but case 2 did not (35% of the tumor was sarcoma). The 4 other cases (cases 8, 10, 20, and 22; atypical spindle cells in the Pap smear. Of the 8 Pap smears with changes diagnostic of malignancy, 5 (63%) had a readily identifiable tumor diathesis, typified by a "dirty" necrotic background (Image 2B), often with many macrophages.
The histologic review confirmed both a carcinomatous and sarcomatous component in every case (examples in Images 1 and 2). Cervical involvement in the hysterectomy specimen correlated positively with an abnormal Pap smear result (P = .04) but not with clinical stage (P = .11) or survival outcome (P = .70). Having an abnormal Pap smear result did not predict which of the 20 patients who underwent hysterectomy would have metastasis (P = 1.0), myometrial invasion (P = .30), or lymphatic or vascular invasion (P = .14). Nearly every tumor contained endometrioid adenocarcinoma and sarcoma of an unspecified type or as a mixture of other varieties ( Table 1 ). The cases that had a carcinoma component in the carcinosarcoma of 50% or more in the resection or curettage specimen were not more likely to have had an abnormal Pap smear result (P = .93).
Almost half of the patients (12/25 [48%]) had a recurrence, and half of the recurrences (6/12) were vaginal. Every vaginal recurrence was discovered on a routine follow-up Pap smear and confirmed by biopsy. The patients who had a vaginal recurrence were more likely to have tumor involving the cervix revealed by hysterectomy (P = .002). Of the 6 cases with a vaginal recurrence, 3 had cervical involvement, 1 did not, and the other 2 had only an endometrial biopsy. This is contrasted with 13 cases that did not have cervical involvement or a vaginal recurrence and only 1 case that had a vaginal recurrence without cervical involvement.
Univariate and multivariate statistical analyses identified features related to survival with an average of 31 months of follow-up (range, 1-150 months) ❚Table 2❚. Patients with stage III or IV disease had a median survival of 8 months in comparison with a median survival of 36 months for those with low-stage disease (P = .006; log-rank test) ❚Figure 1❚. Whereas an abnormal Pap smear result was not associated with a higher clinical stage (P > .8; χ 2 test), Cox proportional hazards model analysis of survival time demonstrated that the presence of an abnormal Pap smear result added significant prognostic information to that provided by clinical stage ❚Table 3❚ and ❚Figure 2❚. In both stage groups, the patients with an abnormal Pap smear result had shorter survival; furthermore, most of the affected patients had stage I or II tumors. The patients with low-stage (I and II) tumor and an abnormal Pap smear result had a decreased median survival from 44 to 36 months, whereas patients with high-stage tumors with an abnormal Pap smear result had a drop in median survival time from 8 months to only 7.5 months.
Discussion
The results of this study show that the conventional Pap smear is insensitive (60% sensitivity) for detecting uterine carcinosarcoma, even on retrospective review. This confirms other reports of 56% to 70% sensitivity. [2] [3] [4] [5] [6] [7] Endometrial aspiration is more effective as shown in small numbers of patients, but this method is used uncommonly. 8 When diagnostic, the malignant cells appear as adenocarcinoma in the Pap smear (Images 1 and 2) . A diagnostic sarcomatous component was consistently absent, even though the tumor often was large and extensive in the curettage or resection specimen.
The Pap smear, even when diagnostic of malignancy, was never diagnostic of carcinosarcoma. Because atypical spindle cells were present in only 8% (2/25) of the Pap smears (Image 1), we found no reliable feature that identified carcinosarcoma specifically on the Pap smear. Heterologous elements usually are identified only on endometrial aspirates. 8 The 2 cases (cases 2 and 6; Table 1 ) that had atypical spindle cells were diagnostic of epithelial malignancy. While a diagnosis of carcinosarcoma could have been suggested in these 2 cases, the differential diagnosis includes a spindle cell component of an endometrial adenosquamous carcinoma and cervical squamous cell carcinoma. Given both the paucity of the nonspecific atypical cells and the relative infrequency of carcinosarcoma in comparison with conventional endometrial adenocarcinoma, we suspect that most cytopathologists interpreting the Pap smear might not be inclined to raise the possibility of carcinosarcoma in the differential diagnosis.
Some investigators have reported a diagnostic sarcomatous component in a very small number of conventional Pap smears, sometimes as rhabdomyoblasts 4 or malignantappearing spindle cells. 2, 3, 6 These studies also found that the majority of abnormal Pap smears had an adenocarcinoma as a more consistent finding. Because the epithelial component typically is represented on an abnormal Pap smear, a carcinosarcoma that has a large carcinomatous portion might be more likely to yield an abnormal Pap smear result. However, the cases in our study with a large carcinomatous component were not more likely to have an abnormal Pap smear result. Our analysis indicates that the sarcomatous component does not shed easily, even when the sarcomatous portion was substantial in size on the resection specimen. However, if the cervix was involved, the Pap smear result was more likely to be abnormal (P = .04). This finding, though, did not affect clinical outcome or correlate with a higher clinical stage. Also, an abnormal Pap smear result was not associated with metastasis, presence or depth of myometrial invasion, or lymphatic or vascular invasion, in contrast with cases of pure adenocarcinoma. 9 Even though the Pap smear may not be a sensitive screening tool for detecting carcinosarcoma of the uterus, significant prognostic information is obtained when the Pap smear result is abnormal. Our outcome data indicate that an abnormal Pap smear result is an important adverse prognostic sign that is stage-independent. As expected, clinical stage showed a strong correlation with outcome ( Figure 1 ), but patients with a high-stage tumor were not more likely to have an abnormal Pap smear result. Similar results have been reported with endometrial adenocarcinoma on Pap smears. 10 Multivariate analysis, which controlled for the obvious effect of stage on outcome, showed that patients with an abnormal Pap smear result had statistically worse outcomes (Table 3 and Figure 2 ). This is the first study, to our knowledge, showing this association. Several speculations about why an abnormal Pap smear result adds information to clinical stage include the following: (1) Current stage definitions are incomplete. (2) Less cell-to-cell adhesion results in an abnormal Pap smear result and implies a more aggressive tumor. If additional studies confirm that an abnormal smear result is an adverse factor and stage-independent, then consideration might be given to incorporating this finding into staging protocols.
The past few years have witnessed a major change in cervicovaginal screening with increasing use of the more sensitive liquid-based techniques. Given that about two thirds of patients with carcinosarcoma had abnormal conventional Pap smear results, it is surmised that at least the epithelial component would be detected more often with the liquid-based techniques, given results for detecting the more common forms of endometrial adenocarcinoma. [11] [12] [13] Perhaps the sarcomatous cells also would be seen more easily, but this component does not seem to shed as easily as the carcinoma. It will be interesting to test whether an abnormal liquid-based screening test result in women with carcinosarcoma will be associated with a worse prognosis independent of stage, as we have demonstrated with conventional Pap smears.
